Factory Price 2-Nitroimidazole CAS NO (527-73-1) In Bulk Quantity

2-Nitroimidazole (527-73-1)

1. Chemical Identity: 2-Nitroimidazole (CAS No. 527-73-1) is a heterocyclic organic compound featuring a five-membered imidazole ring structure with a nitro group (-NO2) attached at the 2nd position. This chemical configuration imparts distinct properties that render it valuable for various applications in pharmaceuticals, agrochemicals, and materials science.

2. Molecular Structure: At a molecular level, 2-Nitroimidazole exhibits a planar geometry due to the conjugation between the imidazole ring and the nitro group. This structural arrangement influences its reactivity, solubility, and interactions with biological targets, laying the foundation for its diverse pharmacological and chemical properties.

3. Pharmacological Significance: 2-Nitroimidazole and its derivatives have garnered attention for their broad spectrum antimicrobial activity, particularly against anaerobic bacteria and protozoa. These compounds serve as essential therapeutics in the treatment of various infectious diseases, including trichomoniasis, giardiasis, and bacterial vaginosis.

4. Synthesis and Production: The synthesis of 2-Nitroimidazole involves the nitration of imidazole under controlled conditions, followed by purification and isolation steps. Various synthetic methodologies have been developed to optimize yield, purity, and scalability, facilitating its production on an industrial scale for pharmaceutical and agricultural applications.

5. Physicochemical Properties: 2-Nitroimidazole typically appears as a pale yellow crystalline solid, exhibiting moderate solubility in water and higher solubility in organic solvents such as ethanol and methanol. Its melting point, boiling point, and other physicochemical properties contribute to its characterization, formulation, and utilization in diverse fields.

6. Mode of Action: Upon administration, 2-Nitroimidazole undergoes metabolic activation within microbial cells, where the nitro group is reduced to generate reactive intermediates. These intermediates disrupt essential cellular processes, including DNA replication and protein synthesis, leading to microbial death or growth inhibition.

7. Therapeutic Applications: In addition to antimicrobial activity, 2-Nitroimidazole derivatives have shown promise in cancer therapy, where they function as radiosensitizers by targeting hypoxic tumor regions. By enhancing the efficacy of radiation therapy, these compounds improve tumor control and patient outcomes in various malignancies, including head and neck cancer and cervical cancer.

8. Toxicological Considerations: While 2-Nitroimidazole compounds exhibit favorable therapeutic profiles, they may pose risks of toxicity at higher doses or prolonged exposure. Adverse effects such as neurotoxicity, genotoxicity, and hepatotoxicity have been reported in preclinical and clinical studies, necessitating careful evaluation of dosage regimens and patient monitoring protocols.

9. Chemical Modifications and Derivatives: Ongoing research efforts focus on the synthesis and evaluation of novel derivatives of 2-Nitroimidazole with improved pharmacokinetic properties, enhanced efficacy, and reduced toxicity profiles. Structural modifications aim to optimize biological activity, increase selectivity, and overcome resistance mechanisms employed by microbial pathogens and cancer cells.

10. Future Perspectives: The continued exploration of 2-Nitroimidazole and its derivatives holds promise for the development of innovative antimicrobial agents, radiosensitizers, and therapeutics for infectious diseases and cancer. Advances in synthetic chemistry, pharmacology, and drug delivery systems pave the way for enhanced treatments, improved patient outcomes, and addressing unmet medical needs in diverse therapeutic areas.